WINDLASPharmaceuticals
Windlas Biotech Ltd — Quarterly Results & Earnings
₹736.75
-1.94%
Profit Growth YoY13.67%Latest quarter
Sales Growth YoY18.93%Latest quarter
Sales CAGR 5Y18.24%5 year compound
Profit CAGR 5Y30.32%5 year compound
📋
Quarterly Performance
YoY Profit Growth+13.67%
✅ Strong growth
YoY Sales Growth+18.93%
✅ Strong growth
OPM 5Y Average
12.13%Operating profit margin
EPS Growth 5Y
2.83%Interest Coverage
19.07Higher = safer debt servicing
ROE
12.76%ROCE
16.96%💡
Growth Analysis
Windlas Biotech Ltd reported YoY profit growth of 13.67% and revenue growth of 18.93% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 18.24% and profits at 30.32% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Windlas Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.